3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Charles Benjamin Malpas, Sifat Sharmin, Jeannette Lechner‐Scott, Nevin John et al.
Citations
1 citations
Topics
Chronic Lymphocytic Leukemia Research
Field-Weighted Citation Impact (FWCI)
0.44
article
3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Charles Benjamin Malpas, Sifat Sharmin, Jeannette Lechner‐Scott, Nevin John, Tomáš Kalinčík, Katherine Buzzard, Helmut Butzkueven, Anneke van der Walt, Izanne Roos, Suzanne Hodgkinson, Michael Harry Barnett, Olga Skibina
article en
1 citations
Abstract
No abstract available for this paper.
Institutions
The Royal Melbourne Hospital (AU), Box Hill Hospital (AU), The University of Melbourne (AU), John Hunter Hospital (AU), The Alfred Hospital (AU), Eastern Health (AU), Mind Australia (AU), Ingham Institute (AU), Hunter New England Local Health District (AU), Monash University (AU)